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We recently identified genes and molecular pathways related to radioresistance of oral squamous cell carcinoma (OSCC) using
Affymetrix GeneChip. The current study focused on the association between one of the target genes, intercellular adhesion molecule
2( ICAM2), and resistance to X-ray irradiation in OSCC cells, and evaluated the antitumor efficacy of combining ICAM2 small
interfering RNA (siRNA) and X-ray irradiation. Downregulation of ICAM2 expression by siRNA enhanced radiosensitivity of OSCC
cells with the increased apoptotic phenotype via phosphorylation (ser473) of AKT and activation of caspase-3. Moreover,
overexpression of ICAM2 induced greater OSCC cell resistance to the X-ray irradiation with the radioresistance phenotype. These
results suggested that ICAM2 silencing is closely related to sensitivity of OSCC cells to radiotherapy, and that ICAM2 may be an
effective radiotherapeutic target for this disease.
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Radiation therapy has played an important role in controlling
tumour growth in many patients with cancer. In patients with oral
squamous cell carcinoma (OSCC), radiation therapy is currently
the standard adjuvant treatment. However, radiation therapy is
sometimes ineffective as cancer cells can be resistant to radiation.
Our previous study showed that the radiosensitivity of OSCC cell
lines differs greatly in their response to X-ray radiation, as
assessed by clonogenic survival assay (Higo et al, 2005). In this
study, we showed that in six OSCC cell lines HSC2 was the most
radioresistant and HSC3 was the most radiosensitive cell line.
Furthermore, we showed that 25 genes and their related molecular
pathways related to cell growth and antiapoptosis were strongly
associated with radiation resistance in OSCC (Ishigami et al, 2007).
Of them, six were reported to be related to cell proliferation and
antiapoptosis, that is, ID1 (Nakajima et al, 1998; Zhang et al,
2004b), ID3 (Plowright et al, 2000; Kowanetz et al, 2004), FGFR3
(Go ´mez-Roma ´n et al, 2005), PEG10 (Okabe et al, 2003; Tsou et al,
2003; Hu et al, 2004), intercellular adhesion molecule 2 (ICAM2)
(Perez et al, 2002), and MMP13 (McCawley and Matrisian, 2000;
Chang and Werb, 2001; Corte et al, 2005), and we validated that the
expression levels increased substantially in radioresistant cells
compared with radiosensitive cells. Among the six genes identified,
ICAM2, whose mRNA level in unirradiated HSC2 (radioresistant
cells compared with unirradiated HSC3 (radiosensitive) cells was
highest in our previous microarray results (Ishigami et al, 2007),
underwent further functional analysis.
Intercellular adhesion molecule 2 has been thought to play a role
in lymphocyte recirculation by blocking LFA-1-dependent cell
adhesion and mediating adhesive interactions important for an
antigen-specific immune response, NK cell-mediated clearance,
lymphocyte recirculation, and other cellular interactions important
for immune response and surveillance (Staunton et al, 1989;
Li et al, 1995; Helander et al, 1996; Carpenito et al, 1997; Lehmann
et al, 2003). However, ICAM2 has been reported to be a mediator
for a survival signal sufficient to block apoptosis by activation of
the PI3K/AKT pathway (Perez et al, 2002). In addition, another
recent study has reported that absence of ICAM2 expression
resulted in impaired angiogenesis in vitro and in vivo, and that
ICAM2-deficient cells were defective in in vitro migration and
increased apoptosis (Huang et al, 2005). It has been shown that
ICAM2-expressing cells may be resistant to apoptosis induced by
anticancer agents, including radiation. Therefore, we hypothesised
that ICAM2 inhibitors could enhance the effect of radiation on
cancer cells that constitutively express ICAM2. Small-interfering
RNA has been used widely to silence gene expression and has been
evaluated as an attractive tool for use in therapeutics of many
cancers (Gao et al, 2005; Zhang et al, 2005; Amarzguioui et al,
2006; Halder et al, 2006; Hosaka et al, 2006). So, we evaluated
whether radiosensitivity of oral cancer cells is determined by
cellular ICAM2 by using siRNA targeted against ICAM2 gene.
Furthermore, we analysed the radiosensitivity of OSCC cells by
upregulating ICAM2 gene expression using expression vector
encoding ICAM2 cDNA.
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Cell lines and culture conditions
The human OSCC-derived cell lines HSC2 and HSC3 (Human
Science Research Resources Bank, Osaka, Japan) were prepared for
this study. The cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma Chemical Co., St Louis, MO,
USA) supplemented with 10% heat-inactivated foetal bovine serum
and 50Uml
 1 penicillin and streptomycin. All cultures were grown
at 371C under a humidified atmosphere of 5% carbon dioxide for
routine growth.
siRNA, transfection reagents, and transfection of siRNAs
in HSC2 (radioresistant) cells
Small-interfering RNAs were obtained from Dharmacon Research
Inc. (Lafayette, CO, USA). SMART pool siRNA targeting ICAM2
consists of four siRNAs targeting multiple sites on ICAM2
(ICAM2-siRNAs). The sequences for ICAM2-siRNAs are 50-AAGC
AGGAGUCAAUGAAUU-30,5 0-UAACCAGCCUGAAGUGGGU-30,
50-UGAGAAGGUAUUCGAGGUA-30, and 50-ACGAACAGGCUCAG
UGGAA-30 (siGENOME SMARTpool, M-11182-00-0005, Human
ICAM2, NM_000873). Positive- and negative-control siRNAs were
purchased from Dharmacon. Two negative controls were used in
this study, that is, vehicle control (treated with only DharmaFECT1
reagent) and siCONTROL non-targeting siRNA pool (D-001210-01-
05; non-targeting siRNA (siNT)). Cyclophilin b (siCONTROL
Cyclophilin b siRNA, D-001136-01-05) was used as positive
silencing control to ascertain transfection efficiency. Cells were trans-
fected with siRNAs using DharmaFECT1 reagent (Dharmacon).
To confirm whether ICAM2 gene is related to radioresistance,
we performed an siRNA experiment to inhibit the expression of
ICAM2 in HSC2 (radioresistant) cell line that previously reported
the expression of ICAM2 as being higher than HSC3 (radio-
sensitive) cell line (Ishigami et al, 2007). HSC2 Cells were plated in
antibiotic-free DMEM at a density of 200000cells4ml
 1 in 60-mm
dishes. After 24h, the cells were transfected with 100nmoll
 1
siRNA in DharmaFECT1 reagent according to the manufacturer’s
instructions. Briefly, 8ml DharmaFECT1 was diluted in 392mlo f
serum-free medium and incubated at room temperature for 5min.
In a separate tube, 200mlo f2mmoll
 1 siRNA was diluted in 200ml
of serum-free medium at room temperature for 5min. Diluted
DharmaFECT1 (400ml) was added to the diluted siRNA and the
complex was incubated for 20min at room temperature. The cells
were washed with antibiotic-free DMEM and 3.2ml antibiotic-free
DMEM was added to each dish. Small interfering RNAþDharma-
FECT1 complex (800ml) was added gently to the dish. The final
concentration of siRNA was 100nmoll
 1. Control cells were
treated with the only medium (HSC2 control), the same amount of
transfection reagents (vehicle control), the 100nmoll
 1 siNT
(negative control), and the 100nmoll
 1 cyclophilin b siRNA
(siCyclophilin b) (positive silencing control). After 4h of
transfection, the medium of cells treated with ICAM2-siRNAs
(siRNA targeted to ICAM2 (siICAM2)) and control cells was
replaced with fresh medium, and these were incubated at 371Ci n
5% CO2 for 48h to 120h before performing experiments.
Transient transfection of ICAM2 DNA
To verify whether ICAM2 gene is related to radioresistance, we
performed overexpression of ICAM2 gene in HSC3 (radiosensitive)
cell line that previously reported the expression of ICAM2 as being
higher than HSC2 (radioresistant) cell line (Ishigami et al, 2007).
Human ICAM2 cDNA was cloned into a pME18SFL3 expression
vector (TOYOBO, Osaka, Japan) for transient transfection experi-
ments. HSC3 cell lines were transfected with pME18SFL3 encoding
ICAM2 cDNA using the FuGENE HD transfection reagent (Roche
Diagnostics GmbH, Mannheim, Germany). Mock transfection of
HSC3 cell line cultures with the FuGENE HD transfection reagent
alone was used as vehicle controls. Transfection efficiency was
confirmed by real-time quantitative reverse transcriptase–poly-
merase chain reaction (qRT–PCR) and western blot analysis.
These analyses were performed as described below.
Irradiation using X-ray
The cells were irradiated with four single radiation doses (2, 4, 6,
and 8Gy) using X-ray irradiation equipment (MBR-1520R-3;
Hitachi, Tokyo, Japan) operated at 150V and 20mA with AL
filtration, at a dose of 2.1Gymin
 1.
Isolation of RNA
Total RNA was extracted from X-ray-irradiated and unirradiated
cells with TRIzor reagent (Invitrogen Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s instructions. The
quality of the total RNA was determined using Bioanalyzer
(Agilent Technologies, Palo Alto, CA, USA).
Preparation of cDNA
Total RNA was extracted from cells using TRIzor reagent. Five
micrograms of total RNA of each sample were reversed transcribed
to cDNA using Ready-To-Go You-Prime First-Strand Beads (GE
Healthcare, Little Chalfort, Buckinghamshire, UK) and oligo (dT)
primer (Sigma Genosys, Ishikari, Japan), according to the
manufacturers’ protocol.
Analysis of mRNA expression by real-time qRT–PCR
Quantitative reverse transcriptase–polymerase chain reaction was
performed to validate mRNA expression with a single method
using a LightCycler FastStart DNA Master SYBR Green I kit (Roche
Diagnostics GmbH), according to the procedure provided by the
manufacturer. The oligonucleotides used as primers were 50-GATC
CAGGGCGGAGACTTC-30 and 50-GCCCGTAGTGCTTCAGTTTG
A-30 for Cyclophilin b mRNA, 50-CATCTCTGCCCCCTCTGCTGA-
30 and 50-GGATGACCTTGCCCACAGCCT-30 for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA, and 50-ATTCAACAG
CACGGCTGACA-30 and 50-CAGGCTCATAGATCTCCAACATC
T- 30 for ICAM2 mRNA. Using LightCycler apparatus, we carried
out PCR reactions in a final volume of 20ml of a reaction mixture
consisting of 2ml of FastStart DNA Master SYBR Green I mix, 3mM
MgCl2, and 1ml of the primers, according to the manufacturer’s
instructions. Subsequently, the reaction mixture was loaded into
glass capillary tubes and subjected to initial denaturation at 951C
for 10min, followed by 33–45 rounds of amplification at 951C
(10s) for denaturation, 62–681C (10s) for annealing, and 721C for
extension, with a temperature slope of 201Cs
 1, performed with
LightCycler. The transcript amount for the genes was estimated
from the respective standard curves and normalised to the GAPDH
transcript amount determined in the corresponding samples.
Protein extraction
Protein was extracted from the cells, which were washed twice with
phosphate-buffered saline, scraped into a tube with lysis buffer
(7 M urea, 2 M thiourea, 4% w/v CHAPS, and 10mM Tris, pH 8), and
incubated at 41C for 10min. Cell extracts were lysed by sonication
(3 10-s pulses on ice) and centrifuged at 13000g for 10min at
41C. The supernatant containing the cell proteins then was
recovered. Protein concentration was determined using a com-
mercial Bradford reagent (Bio-Rad, Richmond, CA, USA) and
adjusted to 1mgml
 1 with lysis buffer.
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Protein extracts (15mg) were electrophoresed on 12.5% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gels, trans-
ferred to polyvinylidene difluoride (PVDF) membrane (Bio-Rad,
Hercules, CA, USA), and blocked for 1h at room temperature in
0.3% skimmed milk. Immunoblot PVDF membranes were washed
with Tris-buffered saline Tween-20 (TBST: 10mM Tris-HCl (pH
8.5), 150mM NaCl, and 0.1% Tween-20) thrice and probed with
2mgml
 1 affinity-purified mouse anti-human ICAM2 monoclonal
antibody (R&D Systems Inc., Minneapolis, MN, USA), 1mgml
 1
affinity-purified rabbit anti-human/mouse/rat specific AKT anti-
body (Rockland Inc., Gilbertsville, PA, USA), and 1mgml
 1
affinity-purified mouse anti-human p-AKT (pS437) antibody
(BIOMOL International, L.P., Plymouth Meeting, PA, USA) over-
night at room temperature. For cyclophilin b protein and b-actin
protein, 1mgml
 1 affinity-purified rabbit anti-human cyclophilin
b polyclonal antibody (Abcam Ltd, Cambridge, UK) and 1mgml
 1
affinity-purified mouse anti-human b-actin monoclonal antibody
(Abcam Ltd) were used for 2h at room temperature. Polyvinyli-
dene difluoride membranes were washed again and incubated with
1:10000 of Envisionþ(Dako Japan Inc., Kyoto, Japan) as
secondary antibody coupled to horseradish peroxidase-conjugated
anti-mouse or ant-rabbit IgG antibody for 2h at room tempera-
ture. Finally, membranes were incubated using the ECL Plus
Western Blotting Detection System (GE Healthcare, Carpinteria,
Buckinghamshire, UK) and immunoblotting result was visualised
by exposing the membrane to Fuji Medica X-Ray film RX-U
(FUJIFILM, Kanagawa, Japan). Signal intensities were quantitated
using ImageJ software (1.38x version)(NIH, Bethesda, MD, USA).
Cell-proliferation assay
To determine the effect of ICAM2 siRNA on cell proliferation,
HSC2 cells transfected with non-targeting or ICAM2 siRNA
(100nmoll
 1) were seeded in 12-well plates at a density of
1 10
4 viable cells per well. Mock-transfected cells were treated
with DharmaFECT1 reagent as vehicle controls but not siRNA. At
the indicated time point, cells were trypsinised and counted using
a haemocytometer in triplicate samples. The effect on cell
proliferation was investigated in the same manner as HSC3 cells
treated with expression vector of ICAM2 DNA.
Clonogenic cell survival assay
HSC2 cells were transfected as above with the vehicle, siNT, and
siICAM2. At 72, 84, and 96h after transfection, the cells were
trypsinised, counted, and the appropriate number of cells were
plated in 60-mm dishes and allowed to attach for 24h. After 24h,
the cells were irradiated (2, 4, 6, 8Gy) and incubated for 8–10 days.
The colonies were stained with crystal violet (Sigma Chemical Co.),
and colonies of 50 cells or greater were counted. Clonogenic
fractions of irradiated cells were normalised to the plating efficiency
of unirradiated controls. Likewise, colonies of HSC3 cells transfected
with expression vector of ICAM2 DNA were measured.
In situ cell apoptosis detection assay
HSC2 cells were plated in 24-well dishes at a density of 2 10
4 cells
per well. After 24h, HSC2 cells were treated with siRNA (vehicle,
siNT, siICAM2). After incubation for 120h, cells were analysed
for apoptosis by terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick-end labelling (TUNEL) procedure, using an
in situ apoptosis detection kit (Takara Bio, Shiga, Japan). Briefly,
cells were fixed in 4% paraformaldehyde for 15min. After
treatment with permeabilisation buffer (Takara Bio) for 2min on
ice, the cells were incubated with TdT enzymes plus labeling safe
buffer (Takara Bio) at 371C. After 1.5h, the cells were washed with
phosphate-buffered saline and observed by fluorescence micro-
scopy. Cells undergoing apoptosis were specifically labelled with
fluorescein-dUTP with high sensitivity, allowing immediate detec-
tion by fluorescence microscopy. Apoptotic cells were counted and
expressed as a percentage of the total cells. The experiments were
performed in triplicate.
Caspase-3 activity assay
We performed three different assays for caspase-3 activity. Two
assays (using caspase-3 detection kit; Calbiochem, Oxford, UK)
measured the amount of activated caspase-3 in situ in living cells
by a caspase-3 inhibitor (DEVD-FMK) conjugated to FITC as a
fluorescent in situ marker. Fluorescein isothiocyanate-DEVD-FMK
is cell-permeable and nontoxic and irreversibly binds to activated
caspase-3 in apoptotic cells. The FITC label allows direct detection
of activated caspase-3 by fluorescence microscopy or a fluores-
cence microplate reader. In our initial experiment, FITC fluores-
cence was conjugated to the inhibitor, thereby registering a
fluorescent label detected by fluorescence microscopy in cells in
which caspase-3 had been activated. Both cells treated with and
without ICAM2 siRNA (control, vehicle, and siNT) were compared.
Caspase-3 active cells were counted and expressed as a percentage
of the total number of cells. The experiments were performed in
triplicate. For the next experiment, we used a microplate reader to
study the effect. Data were expressed as the difference in activity
among the four data points (control, vehicle, siNT, and siICAM2)
and indicated the amount of caspase-3 activity that remained. The
kit was used according to the manufacturer’s instructions. Briefly,
cells were treated with or without ICAM2 siRNA for 120h, after
which they (about 1 10
6ml
 1) were incubated for 1h with FITC-
DEVD-FMK at 371C. The cells then were washed twice by washing
buffer and then the fluorescence intensity was measured by
fluorescence microscopy and using a fluorescence microplate
reader (Wallac 1420 ARVOsx Multilabel Counter; Perkin-Elmer,
Chiba, Japan), with excitation at approximately 485nm and
emission detection at approximately 535nm. Finally, we per-
formed activated caspase-3 western blot analysis. Monoclonal
antibody to active caspase-3 (Genlantis Inc., San Diego, CA, USA)
was used for detection. Western blot analysis for activated caspase-
3 was performed as described previously.
RESULTS
Transfection efficiency of siRNAs
To ascertain whether conditions for RNA inhibition were optimal
and that transfection efficiency was satisfactory, siCyclophilin b
was used as a positive silencing control. In real-time qRT–PCR
analysis, cyclophilin b mRNA expression decreased by 69% with
siCyclophilin b 48h after transfection (Figure 1A). In western blot
analysis, cyclophilin b was detected as a single band. In cells
transfected with siCyclophilin b, the band diminished significantly
(Po0.01, Student’s t-test), confirming high transfection efficiency
120h after transfection compared with the vehicle, siCONTROL
siNT, and the non-transfected control cells. HSC2 cells transfected
with siCyclophilin b showed little change in the band of cyclophilin
b 96 and 108h after transfection compared with controls
(Figure 1B).
ICAM2 protein levels in HSC2 cells transfected with
siICAM2 and control siRNAs
Figure 1C shows western blot analysis of ICAM2 protein
expression in HSC2 cells 120h after transfection with siRNAs.
This time point was selected by a positive silencing control test in
an siRNA transfection experiment (Figure 1B). The ICAM2 protein
levels in cells transfected with vehicle, siNT, and siICAM2-
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In cells transfected with 100nmoll
 1 siICAM2, ICAM2 protein
level decreased significantly (Po0.01, Student’s t-test) compared
with non-transfected, vehicle-transfected, and the siNT-transfected
cells (Figure 1C). In addition, qRT–PCR analysis showed that
ICAM2 mRNA expression decreased by 67, 97, and 96% in HSC2
cells with siICAM2 compared with non-transfected cells at 24, 48,
and 72h, respectively, after transfection.
ICAM2 protein levels in HSC3 cells transfected with ICAM2
DNA
Figure 1D shows western blot analysis of ICAM2 protein
expression in HSC3 cells 72, 96, and 120h after transfection with
expression vector encoding ICAM2 cDNA. The ICAM2 protein
level increased significantly (Po0.01, Student’s t-test) in cells
transfected with ICAM2 DNA compared with vehicle and non-
transfected control cells (Figure 1D). Furthermore, qRT–PCR
analysis showed that the level of ICAM2 mRNA expression
increased significantly (Po0.01, Student’s t-test) by 4.5 10
6 and
9.4 10
6-fold in HSC3 cells with expression vector encoding
ICAM2 cDNA compared with non-transfected cells 48 and 72h,
respectively, after transfection.
Effect of ICAM2 siRNA and expression vector encoding
ICAM2 cDNA on cell growth
To determine the effect of ICAM2 siRNA and expression vector
encoding ICAM2 cDNA on the growth of the cancer cell lines, a
series of cell growth experiments was carried out. The growth
curves of HSC2 cells showed that treatment with ICAM2 siRNA
inhibited cell growth over a period of 6 days, but cell growth was
not inhibited by vehicle and siNT (Figure 2A). Furthermore, the
growth curve of HSC3 cells showed that treatment with expression
vector encoding ICAM2 cDNA increased cell growth over a period
of 6 days compared with the vehicle (Figure 2B).
Radiosensitivity of HSC2 cells transfected with siICAM2
The plating efficiencies of unirradiated HSC2 cells (mean±s.d.,
n¼3) were 0.278±0.038 (control), 0.270±0.032 (vehicle),
0.262±0.031 (siNT), 0.258±0.031 (siICAM2, 120h), 0.275±0.066
(siICAM2, 108h), and 0.220±0.057 (siICAM2, 96h). The
difference in the plating efficiency of siICAM2 cells compared
with vehicle or siNT cells was not significant. Figure 2C shows the
radiation survival curves of untreated control cells and cells
transfected with siRNAs. These data were used to calculate dose
D37 that is required to reduce survival to 37% (Toulany et al, 2006).
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Figure 1 Effect of siRNAs. (A) Expression of cyclophilin b mRNA in non-transfected HSC2 cells (control) and HSC2 cells transfected with siCyclophilin b
(Po0.01, Student’s t-test). (B) Western blot analysis of cyclophilin b protein (positive control) in HSC2. The cells were transfected with 100nmoll
 1 siNT
and siCyclophilin b and analysed at 96, 108, and 120h. Cyclophilin b and actin bands were scanned and quantitated as described under Materials and
Methods. The values obtained from densitometric analysis of each cyclophilin b protein first were normalised to actin protein levels and then expressed as
the percentage of the values of control. Cyclophilin b proteins were significantly inhibited (Po0.01, Student’s t-test) in cells transfected with siCyclophilin b at
120h. There is no change in cyclophilin b in cells transfected with vehicle and siNT negative controls siRNA. (C) Western blot analysis of ICAM2 protein in
HSC2 cells transfected with vehicle, siNT, and siICAM2. The cells were transfected with 100nmoll
 1 siRNAs and analysed at 120h. Intercellular adhesion
molecule 2 and actin bands were scanned and quantitated as described under Materials and Methods. The values obtained from densitometric analysis of
each ICAM2 protein first were normalised to actin protein levels and then expressed as the percentage of the values of control. The ICAM2 proteins were
significantly inhibited (Po0.01, Student’s t-test) in cells transfected with siICAM2 at 120h. (D) Western blot analysis of ICAM2 in ICAM2-overexpressing
HSC3 cells. The cells were examined 72, 96, and 120h after transient transfection of expression vector encoding ICAM2 cDNA. Actin was used as a loading
control. Intercellular adhesion molecule 2 and actin bands were scanned and quantitated as described under Materials and Methods. The values obtained
from densitometric analysis of each ICAM2 protein first were normalised to actin protein levels and then expressed as the percentage of the values of
control. The ICAM2 protein levels increased significantly (Po0.01, Student’s t-test) in cells transfected with the expression vector of ICAM2 DNA at 72, 96,
and 120h.
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at 108h, siICAM2 at 96h, and siICAM2 at 120h were 7.6, 7.6, 7.7,
6.0, 4.7, and 4.4Gy, respectively. Compared with the vehicle-
treated control, at the 37% survival level, the radiosensitivity of
cells transfected with siICAM2 at 120h was enhanced by a dose-
modifying factor of 1.73 and the radiosensitivity of cells
transfected with siNT was 0.99-fold.
Cells transfected with siICAM2 at 120h compared with
cells transfected with siNT
The radiosensitivity of cells transfected with siICAM2 at 120h was
enhanced by a dose-modifying factor of 1.75 for siNT. Moreover,
survival of HSC2 cells transfected with siICAM2 at 120h decreased
significantly (Po0.01, Student’s t-test) after 4, 6, and 8Gy of
radiation compared with that of HSC2 cells treated with siNT
(Figure 2C). This indicates that radiation-induced sublethal
damage is severe when ICAM2 expression is inhibited.
Radiosensitivity of HSC3 cells transfected with expression
vector of ICAM2 DNA
In HSC3 cells, the plating efficiencies at 0Gy (mean±s.d., n¼3)
were 0.211±0.030 (control), 0.262±0.003 (vehicle), and
0.232±0.030 (ICAM2). The difference in the plating efficiency of
cells transfected with expression vector of ICAM2 DNA, compared
with vehicle or untreated control cells, was not significant. The
radiation survival curves of cells are shown in Figure 2D. In cells
transfected with expression vector encoding ICAM2 cDNA,
compared with cells transfected with vehicle and untreated control
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Figure 2 Effect of ICAM2 expression on cell growth and cell survival. (A) HSC2 cells were transfected with 100nmoll
 1 ICAM2 siRNA (siICAM2), siNT, or
vehicle. At the indicated time points, the cells were trypsinised and counted using a haemocytometer in triplicate samples. The results represent the
mean±s.d. The asterisks indicate significant differences between siNT and ICAM2 siRNA (**Po0.01, Student’s t-test). (B) HSC3 cells were transfected
with expression vector encoding ICAM2 cDNA or vehicle. At the indicated time points, the cells were trypsinised and counted using a haemocytometer in
triplicate samples. The results are expressed as the mean±s.d. The asterisks indicate significant differences between the vehicle and ICAM2 transfectant
(**Po0.01, Student’s t-test). (C) The effect of radiation on the clonogenic survival of HSC2 cells transfected with the vehicle, siNT, and siICAM2. At 72, 84,
and 96h after transfection; the cells were trypsinised and plated for clonogenic survival assay for siICAM2 at 96h, siICAM2 at 108h, and siICAM2 at 120h,
respectively. After 24h, when the cells had attached, they were irradiated. Colonies were stained with crystal violet and counted after 8–10 days. Each
experiment was repeated at least three times; the error bars represent ±s.d. The significance of the difference between siNT (open square) and siICAM2
(closed circle) is indicated by asterisks (**Po0.01, *Po0.05, Student’s t-test). (D) The effect of radiation on the clonogenic survival of HSC3 cells
overexpressing ICAM2, vehicle treated cells, and untreated control. The clonogenic survival of HSC3 cells was calculated in the same way as for HSC2 cells.
The significance of the difference between the vehicle (open triangles) and ICAM2-overexpressing cells (closed circles) is indicated by asterisks (**Po0.01,
*Po0.05, Student’s t-test).
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scells, the radiosensitivity of the transfectant decreased. For HSC3
cells, dose D37 values for control, vehicle, and the transfectant were
3.4, 4, and 5Gy, respectively. The resulting dose-modifying factors
were 0.80 for the vehicle and 0.68 for the untreated control cells at
the 37% survival level. Furthermore, the rate of cell survival of the
transfectant increased significantly (**Po0.01, *Po0.05, Student’s
t-test) after 2, 4, 6, and 8Gy of radiation, compared with that of
cells treated with vehicle (Figure 2D).
Correlation of ICAM2 expression and apoptosis
To examine whether expression of ICAM2 is the result of
apoptosis, we analysed DNA fragmentation by TUNEL assay. As
shown in Figure 3A–D, positive TUNEL labelling in apoptotic cells
was bright. Figure 3D clearly shows that apoptosis was induced in
some cells but not in others (Figure 3A–C). The percentages of
apoptotic cells in HSC2 cells transfected with the vehicle, siNT,
siICAM2, and in the untreated control cells were 1.40±0.09,
2.56±0.29, 26.4±8.81, and 1.05±0.14%, respectively. Data are
expressed as the mean±s.d. of three independent experiments.
The difference between siNT and siICAM2 reached significance
(Po0.01, Student’s t-test).
ICAM2-induced AKT phosphorylation
Recent studies have reported that ICAM2 activated the protein
kinase B (PKB)/AKT pathway leading to inhibition of apoptosis
(Perez et al, 2002). In this pathway, phosphorylation (Ser473) of
AKT protein induced antiapoptosis. To investigate the correlation
of ICAM2 and AKT phosphorylation, we performed western blot
analysis with antibody recognising AKT and AKT phosphorylation
at Ser473 site (Figure 3I). Figure 3I shows that HSC2 cells treated
with siICAM2 resulted in lower AKT phosphorylation level than
cells treated with the vehicle, siNT, and the untreated control cells.
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Figure 3 The effects of ICAM2 inhibition on apoptosis in HSC2 cells. DNA fragmentation of apoptotic cells is detected by TUNEL assay. (D) HSC2 cells
were treated with 100nmoll
 1 siICAM2 for 120h. Many apoptotic cells are detected in HSC2 cells with siICAM2. (A–C) Few apoptotic cells are detected
in cells transfected with the vehicle, siNT, and in untreated control cells. (E–H) The lower panels are phase-contrast micrographs showing total cells.
Bar¼35mm. (I) Western blot analyses of AKT and p-AKT (AKT phosphorylation at the Ser473 site) protein in HSC2 cells transfected with the vehicle,
siNT, siICAM2, and in untreated control. The cells were transfected with 100nmoll
 1 siRNAs and analysed at 120h. p-AKT and AKT bands were scanned
and quantitated as described under Materials and Methods. The values obtained from densitometric analysis for each AKT proteins were first normalised to
AKT protein levels and then expressed as the percentage of the values for the control. The p-AKT proteins were significantly inhibited (Po0.01, Student’s
t-test) in cells transfected with siICAM2 at 120h.
ICAM2 siRNA enhanced radiation sensitivity
T Ishigami et al
1362
British Journal of Cancer (2008) 98(8), 1357–1365 & 2008 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
sCaspase-3 activity assay
We investigated the role of caspase-3 in this process to determine
the mechanism by which apoptosis occurred. Figure 4A–D show
the green FITC signal present within the siICAM2 cells; control,
vehicle, and siNT cells displayed a small activated caspase-3 signal.
The percentages of caspase-3 active cells in HSC2 cells transfected
with the vehicle, siNT, siICAM2, and the untreated control cells
were 2.60±2.30%, 4.00±0.61%, 20.7±0.71%, and 1.45±2.51%,
respectively. Data are expressed as the mean±s.d. of three
independent experiments. The difference between siNT and
siICAM2 reached significance (Po0.01, Student’s t-test). The
second assay (caspase-3 activity assay) (Figure 4I) showed that
caspase-3 activity was significantly elevated in cells with ICAM2
siRNA for 120h compared with cells with vehicle and siNT
(Po0.05, Student’s t-test). Quantification of relative fluorescence
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Figure 4 The effect of ICAM2 inhibition on caspase-3 activity in HSC2 cells. (D) HSC2 cells treated with 100nmoll
 1 siICAM2 for 120h. Relatively more
caspase-3 active cells are detected in HSC2 cells with siICAM2. (A–C) Few caspase-3 active cells are detected in cells transfected with the vehicle, siNT,
and in untreated control cells. (E–H) The lower panels are phase-contrast micrographs showing total cells. Bar¼35mm. (I) HSC2 cells were treated with
ICAM2 siRNA for 120h and the activity of caspase-3 was measured using the caspase-3 detection kit with a microplate reader as described under Materials
and Methods. The results are expressed as mean±s.d. of three independent experiments. Caspase-3 activity is increased significantly (Po0.05, Student’s t-
test) in cells transfected with siICAM2 at 120h. (J) Western blot analysis of active caspase-3 protein in HSC2 cells transfected with the vehicle, siNT, and
siICAM2. Cells were transfected with 100nmoll
 1 siRNAs and analysed at 120h. Active caspase-3 and actin bands were scanned and quantitated as
described under Materials and Methods. The values obtained from densitometric analysis for each active caspase-3 protein were first normalised to actin
protein levels and expressed as the percentage of the control values. Active caspase-3 protein levels are increased significantly (Po0.01, Student’s t-test) in
cells transfected with siICAM2 at 120h.
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sintensity revealed that siICAM2 increased caspase-3 enzymatic
activity 1.36-fold compared with siNT. The third study examined
the protein levels of active caspase-3. Figure 4J shows that HSC2
cells treated with siICAM2 had significantly higher (Po0.01,
Student’s t-test) active caspase-3 protein levels than cells treated
with the vehicle, siNT, and the untreated control cells.
DISCUSSION
ICAM2, whose mRNA level was upregulated in radioresistant
OSCC cells in our previous study (Ishigami et al, 2007), was one of
candidate genes selected as radioresistant genes of OSCC cells by
microarray analysis using Affymetrix GeneChip.
The current study was designed to examine whether ICAM2 is
functionally associated with radiosensitivity of OSCC in vitro.I n
the previous report, little has been mentioned about the role of
ICAMs in regard to radioresistance. Intercellular adhesion
molecule 1 expression was shown to be elevated by hypoxia and
radiation (Zu ¨nd et al, 1997; Meineke et al, 2002). Intercellular
adhesion molecule 3 expression was reported to associate with
radioresistance in cervical cancer (Chung et al, 2005).
In our study, the results indicated that ICAM2 inhibition
induces radiosensitive in vitro (Figure 2C). A further important
point is that radiosensitisation of cells may depend on the extent of
ICAM2 protein inhibition. Because HSC2 cells were incubated for a
longer time with siICAM2, they became more radiosensitive
(Figure 2C), suggesting that radiosensitisation of HSC2 cells may
be determined by the amount of ICAM2 protein present in the cells
at the time of irradiation. Moreover, ICAM2 overexpression
induces radioresistance in vitro (Figure 2D). These results may
indicate that regulation of ICAM2 protein is correlated with
radiosensitivity. Further, Figure 2A and B show that regulation of
ICAM2 protein is related to cell growth. The question that needs to
be answered is what mechanisms play a role in the relation
between the regulation of the ICAM2 protein and these results.
Intercellular adhesion molecule 2-induced activation of AKT
kinase resulted in the activation of several downstream effectors as
detected by phosphorylation of BAD, GSK3, FKHR, and AFX, all of
which can contribute to cell survival (Zha et al, 1996; Brunet et al,
1999). The PI3/AKT-signalling system is a general mediator of
extracellular stimuli, including growth factors, cytokines, and
adhesion, to extracellular matrices (Downward, 1998). Phosphati-
dylinositol-3,4,5-triphosphate binds to the pleckstrin domain of
AKT and recruits AKT to the membrane, where it becomes dually
phosphorylated (Alessi et al, 1996) and is then activated and
phosphorylates a number of downstream effectors that contribute
to cell survival. These studies indicated that ICAM2 activation
might lead to an antiapoptic signal in a variety of cells. A recent
study identified a pathway of ICAM2 activating the PI3K/AKT
leading to inhibition of apoptosis (Perez et al, 2002). This pathway
showed that ICAM2 induced tyrosine phosphorylation of ezrin and
PI3K kinase membrane translocation, resulting in phosphatidyli-
nositol-3,4,5 production, PDK-1 and AKT activation, and sub-
sequent phosphorylation of AKT targets BAD, GSK3, and FKHR.
The previous studies may have presumed that the differences in
cell growth and radiosensitivity are caused by mechanisms of
antiapoptotic effect induced by ICAM2. Consequently, we postu-
lated that ICAM2 induced antiapoptosis in OSCCs as well as the
mechanism of the PKB/AKT pathway activation previously
reported (Perez et al, 2002). In addition, AKT phosphorylation at
Ser473 was suggested to be correlated perfectly with antiapoptosis
in lymphocytes (Perez et al, 2002). Therefore, we examined AKT
phosphorylation (Ser473) and cell apoptosis to confirm the
relation between ICAM2 and antiapoptosis via the PKB/AKT
pathway in OSCC cells. The results of our experiment showed that
cells with siICAM2 induced a decrease in AKT phosphorylation
(Ser473) (Figure 3I). To detect cell apoptosis, we performed
caspase-3 activity assays and TUNEL assay. We evaluated caspase-
3 activation in cells treated with ICAM2 siRNA. HSC2 cells treated
with siICAM2 showed increased caspase-3 activity compared with
untreated or control cells (Figure 4). In the previous studies, the
apoptotic pathway induced by decrease in p-AKT caused
activation of caspase-3 (Ivins Zito et al, 2004; Zhang et al, 2004a;
Zhuang et al, 2007). We considered that decreased p-AKT and
increased activated caspase-3 induced apoptosis in cells treated
with ICAM2 siRNA. Furthermore, results of the TUNEL assay
showed increased apoptosis (Figure 3D). Accordingly, it is
reasonable that inhibiting ICAM2 may contribute to radio-
sensitisation of OSCC cells by increased apoptosis via phosphory-
lation (Ser473) of AKT and activation of caspase-3.
Our study was similar to a previous study (Chung et al, 2005) in
which the investigators used the same methods, that is, microarray
analysis, siRNA, overexpression, and apoptosis assay. These two
studies yielded similar results in that they both confirmed a
relation between a gene and radioresistance. However, due to
availability of clinical samples, our study differed from the other in
that we could not analyse clinical specimens from patients. Our
study, therefore, may be insufficient in vivo. Our study could not
prove a relation between ICAM2 and radioresistance in OSCC cells
in vitro.
In conclusion, ICAM2 expression may be associated with
radioresistance in OSCC cells, ICAM2 siRNA may enhance the
radiosensitivity of oral cancer cells, and ICAM2 may be an effective
radiotherapeutic target of oral cancer and a marker for radiation
sensitivity based on in vitro studies with microarray analysis.
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